Healthcare Stocks
Recent market-moving SEC filings and news across healthcare companies, ranked by Wiseek's 1–10 importance score.
Browse Healthcare by industry
Healthcare covers these industries — each with its own live feed of market-moving events:
Biotech StocksMedical Device StocksPharmaceutical StocksHealth Tech StocksDiagnostics & Research StocksMedical Instrument StocksHealthcare Facility Stocks
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a healthcare company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
NewcelX Appoints World-Renowned Diabetes Expert Dr. Camillo Ricordi to Scientific Advisory Board
Evolus Partners with IBSA for Exclusive U.S. Rights to Market-Leading Profhilo® Skin Quality Injectable
Hyperion DeFi Finalizes New Employment Agreements for CEO, CFO, and General Counsel
GE HealthCare Faces Securities Fraud Probe After Q1 Profit Cut, 13% Stock Drop
DeepSolar AI Platform Validated, Nearing Commercial Launch for Renewable Energy Optimization
IRIDEX Issues Shares to 10% Owner for Convertible Note Interest Payment
Seer Board Urges Shareholders to Vote 'FOR' Current Nominees, Defends Against Activist Takeover
GMR Solutions Finalizes Key Board Committee Assignments for Lead Independent Director
Shareholders Approve Esperion Therapeutics Acquisition by Essence Parent
GMR Solutions Appoints Two Highly Experienced Healthcare Leaders to Board, Completing Post-IPO Structure
Vaccinex to Present Promising Biomarker Data, Unveil Enlarged Phase 2B Alzheimer's Trial Plans
DeepSolar AI Platform Validated for Renewable Energy Optimization, Nearing Commercial Launch
Azenta Completes $63M B Medical Systems Sale, Provides $35M Vendor Loan to Buyer
Seres Therapeutics' SER-155 achieves 80% immunosuppressive-free response in irEC trial
Prime Medicine Wins Key Arbitration, PM647 IP Confirmed; Beam's Claims for Damages Denied
Prime Medicine Wins Arbitration Against Beam Therapeutics, Securing PM647 Rights
60 Degrees Pharma Secures Exclusive Option for Castanospermine in Tick-Borne Diseases
Alkermes Terminates Authorized Generic Agreement for VIVITROL®
Seres Therapeutics Reports Positive SER-155 Clinical Data for irEC, Bolstering Partnership Efforts
FDA Clears UroGen's Next-Gen Oncolytic Virus UGN-501 for Bladder Cancer Clinical Trials
FDA accepts Arcutis' Zoryve sNDA for infant atopic dermatitis; PDUFA set for Feb 2027
Acurx Pharmaceuticals Sets August 14 for Q2 2026 Earnings Call and Business Update
Chemomab Therapeutics to Merge with Precision Medicine Pioneer Scipher Medicine
Chemomab Therapeutics to Merge with Scipher Medicine in Reverse Acquisition, Valued at $150M Pre-PIPE
Aura Biosciences Appoints New Director, Boosts Board Compensation
BioLineRx Reports Strong Preclinical Synergy for GLIX1 in Ovarian Cancer
Ovid Therapeutics Appoints New CFO Charles Carter Following CBFO Jeffrey Rona's Departure
Controlling Shareholder Richard Griffiths Reduces Stake to 21.7% After $16.3M Sales
FDA Validates Urcosimod Phase 3 Path for Neuropathic Corneal Pain, Eyes Single-Trial Registration
FDA Greenlights OKYO Pharma's Urcosimod for Pivotal Phase 3 Trial in Neuropathic Corneal Pain
Ovid Therapeutics Bolsters Executive Team with New CBO, R&D Advisor, and Key Promotions
BioLineRx's GLIX1 Shows Strong Synergy with PARP Inhibitors in Ovarian Cancer, Plans Trial Expansion
Evogene Forms Joint Initiative with Tel Aviv University to Boost AI-Driven Drug Discovery
Satellos Reports Positive Six-Month Interim Data for SAT-3247 in Adult DMD Patients
SAT-3247 Shows Positive Six-Month Data in DMD Adults, Reducing Muscle Fat and Improving Effort
Aethlon Medical Secures $4.0M in Highly Dilutive Registered Offering at $0.71
FDA Warning Letter Hits Amphastar Subsidiary for Manufacturing Compliance
Centene, Elevance Seek Steep 2027 Obamacare Rate Hikes, Centene Up 28%
Major Shareholder Disposes of 500,000 Scilex Shares to Fund Acquisition
GeneDx Hit with Class Action Lawsuit Over Fabric Genomics Acquisition